BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8019699)

  • 1. Insulin structure and stability.
    Brange J; Langkjoer L
    Pharm Biotechnol; 1993; 5():315-50. PubMed ID: 8019699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.
    Brange J; Langkjaer L; Havelund S; Vølund A
    Pharm Res; 1992 Jun; 9(6):715-26. PubMed ID: 1409351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical stability of insulin. 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation.
    Brange J
    Acta Pharm Nord; 1992; 4(4):209-22. PubMed ID: 1294186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.
    Brange J; Langkjaer L
    Acta Pharm Nord; 1992; 4(3):149-58. PubMed ID: 1418641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products.
    Brange J; Hallund O; Sørensen E
    Acta Pharm Nord; 1992; 4(4):223-32. PubMed ID: 1294187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues.
    Whittingham JL; Edwards DJ; Antson AA; Clarkson JM; Dodson GG
    Biochemistry; 1998 Aug; 37(33):11516-23. PubMed ID: 9708987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
    Zoete V; Meuwly M; Karplus M
    J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structures of the R6 human insulin hexamer,
    Chang X; Jorgensen AM; Bardrum P; Led JJ
    Biochemistry; 1997 Aug; 36(31):9409-22. PubMed ID: 9235985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of insulin in amyloid fibrils.
    Nilsson MR; Dobson CM
    Protein Sci; 2003 Nov; 12(11):2637-41. PubMed ID: 14573875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure of insulin: the insulin monomer and its assembly.
    Derewenda U; Derewenda Z; Dodson GG; Hubbard RE; Korber F
    Br Med Bull; 1989 Jan; 45(1):4-18. PubMed ID: 2676073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.
    Markussen J; Diers I; Hougaard P; Langkjaer L; Norris K; Snel L; Sørensen AR; Sørensen E; Voigt HO
    Protein Eng; 1988 Jul; 2(2):157-66. PubMed ID: 3072564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorption of insulin with varying self-association profiles to a solid Teflon surface--influence on protein structure, fibrillation tendency and thermal stability.
    Jorgensen L; Bennedsen P; Hoffmann SV; Krogh RL; Pinholt C; Groenning M; Hostrup S; Bukrinsky JT
    Eur J Pharm Sci; 2011 Apr; 42(5):509-16. PubMed ID: 21352910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations.
    Brange J; Havelund S; Hougaard P
    Pharm Res; 1992 Jun; 9(6):727-34. PubMed ID: 1409352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.
    Strickley RG; Anderson BD
    Pharm Res; 1996 Aug; 13(8):1142-53. PubMed ID: 8865303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the mechanism of insulin fibril formation with insulin mutants.
    Nielsen L; Frokjaer S; Brange J; Uversky VN; Fink AL
    Biochemistry; 2001 Jul; 40(28):8397-409. PubMed ID: 11444987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of an engineered insulin monomer at neutral pH.
    Olsen HB; Ludvigsen S; Kaarsholm NC
    Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer.
    Derewenda U; Derewenda Z; Dodson EJ; Dodson GG; Reynolds CD; Smith GD; Sparks C; Swenson D
    Nature; 1989 Apr; 338(6216):594-6. PubMed ID: 2648161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation.
    Strickley RG; Anderson BD
    J Pharm Sci; 1997 Jun; 86(6):645-53. PubMed ID: 9188045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review.
    Dunn MF
    Biometals; 2005 Aug; 18(4):295-303. PubMed ID: 16158220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
    Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
    J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.